Skip to main content
. Author manuscript; available in PMC: 2024 Feb 5.
Published in final edited form as: Sci Transl Med. 2024 Jan 17;16(730):eadf9735. doi: 10.1126/scitranslmed.adf9735

Table 1. Patient characteristics in cohort with TMEM106B rs3173615 SNP status.

The sample median (minimum, maximum) is given for continuous variables, and number of cases (percentages) is provided for categorical variables. Information was unavailable regarding age at onset and survival after symptom onset (n = 22).

Characteristic FTLD-TDP (N = 228)
Sex (female) 106 (46.5%)
Age at onset (years) 64.72 (39.98, 86.49)
Survival after onset (years) 8.00 (1.00, 25.00)
Age at death (years) 74.16 (49.98, 99.56)
TMEM106B rs3173615
CC/TT185 106 (46.5%)
CG/TS185 104 (45.5%)
GG/SS185 18 (7.9%)